Type 2 Diabetes
The Type 2 Diabetes pipeline: 145 tracked drugs, 38 approved for this indication.
38 approved / phase 466 Phase 325 Phase 29 Phase 12 US approval withdrawn5 preclinical / unstaged
Compare the share prices of listed companies in Type 2 Diabetes →
Total attributable cost
$324.6B
$12,022/patient
Drug spend
$126.1B
$4,670/patient
All severities · US
The Type 2 Diabetes pipeline
Key trial results for every approved and late-stage drug: Type 2 Diabetes results by drug.